These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Insulin antibodies in untreated and insulin-treated diabetics]. Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989 [No Abstract] [Full Text] [Related]
25. Immunobiological studies in two cases of insulin-resistant diabetes. de Assis LM; Nicolau W; Salomon JB; de Cintra AB; Pieroni RR AMB Rev Assoc Med Bras; 1970 Jan; 16(1):5-18. PubMed ID: 5311115 [No Abstract] [Full Text] [Related]
26. [Determination of the insulin antibody titre in severe form of diabetes mellitus]. Pliats OM; Alekseev IuP Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624 [TBL] [Abstract][Full Text] [Related]
27. Behaviour of insulin antibodies in diabetics treated with different insulins. Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044 [TBL] [Abstract][Full Text] [Related]
28. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics. Sekso M; Resetić J; Riznar V; Solter M Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291 [No Abstract] [Full Text] [Related]
29. [Interrelations of blood levels of contrainsular hormones and titers of insulin antibodies in diabetics treated with insulin]. Vakov L Vutr Boles; 1986; 25(6):70-3. PubMed ID: 3551331 [TBL] [Abstract][Full Text] [Related]
30. [Molecular size of insulin-anti-insulin immune complexes in the serum of diabetic patients]. Brizzio AM; Nieto RR; Cedola N; Poskus E; Gagliardino JJ Medicina (B Aires); 1988; 48(2):113-9. PubMed ID: 3068475 [No Abstract] [Full Text] [Related]
31. [Autoimmune connections between diabetes and Addison-Biermeier disease]. Rechowicz K; Pawelski S; Konopka L; Czech A; Czyzyk A Pol Tyg Lek; 1973 Sep; 28(35):1341-3. PubMed ID: 4745914 [No Abstract] [Full Text] [Related]
33. Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus. Kilpatrick JM; Virella G Clin Exp Immunol; 1980 Jun; 40(3):445-52. PubMed ID: 6998615 [TBL] [Abstract][Full Text] [Related]
34. [Insulin-binding antibodies and insulin resistance (author's transl)]. Waldhäusl W Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340 [No Abstract] [Full Text] [Related]
37. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment]. Bruni B; Turco GL Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430 [No Abstract] [Full Text] [Related]
38. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
39. [The effect of antibodies on the activity and kinetics of administered insulin]. Páv J; Srámková J Cas Lek Cesk; 1982 Oct; 121(41):1258-61. PubMed ID: 6756634 [No Abstract] [Full Text] [Related]
40. [Serum levels of insulin-binding antibodies treated with monocomponent insulin]. Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]